Thyroid disease and vascular function

被引:82
作者
Owen, Penelope J. D. [1 ]
Sabit, Ramsey [1 ]
Lazarus, John H. [1 ]
机构
[1] Cardiff Univ, Ctr Endocrine & Diabet Sci, Llandough Hosp, Sch Med, Penarth CF14 4XN, S Glam, Wales
关键词
D O I
10.1089/thy.2007.0051
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Altered cardiac function in thyroid disease is well recognized and has been extensively investigated, vascular function has however been less well studied in those with thyroid dysfunction. Thyroid hormones, thyroxine (T-4) and triiodothyronine (T-3) are important regulators of cardiac function and cardiovascular hemodynamics. The cardiovascular system responds to minimal but persistent changes in circulating thyroid hormone levels producing changes in vascular reactivity and endothelial function. The detection of endothelial dysfunction and/or arterial stiffness allows early identification of individuals at risk as these occur in both patients with risk factors for coronary artery disease and in those with established disease. This may allow treatment to be targeted at high risk individuals with the aim of slowing the progression of vascular disease. The various methods used to assess arterial function are reviewed and the changes demonstrated in human and animalmodels of thyroid dysfunction.
引用
收藏
页码:519 / 524
页数:6
相关论文
共 79 条
[1]   Thyroid function is associated with presence and severity of coronary atherosclerosis [J].
Auer, J ;
Berent, R ;
Weber, T ;
Lassnig, E ;
Eber, B .
CLINICAL CARDIOLOGY, 2003, 26 (12) :569-573
[2]   Hypothyroidism as a risk factor for cardiovascular disease [J].
Biondi, B ;
Klein, I .
ENDOCRINE, 2004, 24 (01) :1-13
[3]   Effects of thyroid hormone on cardiac function: The relative importance of heart rate, loading conditions, and myocardial contractility in the regulation of cardiac performance in human hyperthyroidism [J].
Biondi, B ;
Palmieri, EA ;
Lombardi, G ;
Fazio, S .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (03) :968-974
[4]   CARDIAC EFFECTS OF LONG-TERM THYROTROPIN-SUPPRESSIVE THERAPY WITH LEVOTHYROXINE [J].
BIONDI, B ;
FAZIO, S ;
CARELLA, C ;
AMATO, G ;
CITTADINI, A ;
LUPOLI, G ;
SACCA, L ;
BELLASTELLA, A ;
LOMBARDI, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (02) :334-338
[5]   Impact of aortic stiffness on survival in end-stage renal disease [J].
Blacher, J ;
Guerin, AP ;
Pannier, B ;
Marchais, SJ ;
Safar, ME ;
London, GM .
CIRCULATION, 1999, 99 (18) :2434-2439
[6]   Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients - A longitudinal study [J].
Boutouyrie, P ;
Tropeano, AI ;
Asmar, R ;
Gautier, I ;
Benetos, A ;
Lacolley, P ;
Laurent, S .
HYPERTENSION, 2002, 39 (01) :10-15
[7]   Endothelial function in patients with hyperthyroidism before and after treatment with propranolol and thiamazol [J].
Burggraaf, J ;
Lalezari, S ;
Emeis, JJ ;
Vischer, UM ;
de Meyer, PHEM ;
Pijl, H ;
Cohen, AF .
THYROID, 2001, 11 (02) :153-160
[8]   Hyperthyroidism enhances endothelium-dependent relaxation in the rat renal artery [J].
Büssemaker, E ;
Popp, R ;
Fisslthaler, B ;
Larson, CM ;
Fleming, I ;
Busse, R ;
Brandes, RP .
CARDIOVASCULAR RESEARCH, 2003, 59 (01) :181-188
[9]   The Colorado thyroid disease prevalence study [J].
Canaris, GJ ;
Manowitz, NR ;
Mayor, G ;
Ridgway, EC .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (04) :526-534
[10]   Evaluation of endothelial function in subclinical hypothyroidism and subclinical hyperthyroidism [J].
Cikim, AS ;
Oflaz, H ;
Ozbey, N ;
Cikim, K ;
Umman, S ;
Meric, M ;
Sencer, E ;
Molvalilar, S .
THYROID, 2004, 14 (08) :605-609